For instance, the most common oncogenic molecular alteration in NSCLC is in EGFR; these alterations are found in 10% to 50% of patients with NSCLC depending upon demographics such as ethnicity, gender, smoking history, and histology [13]. Here, EGFR is linked to non-small cell lung carcinoma.